SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000926617-22-000064
Filing Date
2022-12-02
Accepted
2022-12-02 08:34:04
Documents
12
Period of Report
2022-11-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K awh-20221129x8k.htm   iXBRL 8-K 74679
  Complete submission text file 0000926617-22-000064.txt   198116

Data Files

Seq Description Document Type Size
2 EX-101.SCH awh-20221129.xsd EX-101.SCH 2550
3 EX-101.LAB awh-20221129_lab.xml EX-101.LAB 15612
4 EX-101.PRE awh-20221129_pre.xml EX-101.PRE 11194
6 EXTRACTED XBRL INSTANCE DOCUMENT awh-20221129x8k_htm.xml XML 5068
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34810 | Film No.: 221440344
SIC: 2835 In Vitro & In Vivo Diagnostic Substances